Inventor · disambiguated record
Christophe Meyer
Also filed as: MEYER CHRISTOPHE
27 granted patents·4 pending applications·88 citations·filing 2003–2021
94Inventor score
Files withJANSSEN PHARMACEUTICA NV16BONFANTI JEAN-FRANCOIS3LACRAMPE JEAN FERNAND ARMAND2TIBOTEC PHARM LTD2VIALARD JORGE EDUARDO2
Top patents by PatentIndex Score
31 records- 0188US8299256B2Quinolinone derivatives as PARP and TANK inhibitorsVIALARD JORGE EDUARDO·Filed 2008·Granted Oct 30, 2012·17 cites·9 claims
- 0286US10077261B2Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 18, 2018·7 cites·16 claims
- 0386US8404713B2Quinolinone derivatives as PARP inhibitorsANGIBAUD PATRICK RENE·Filed 2008·Granted Mar 26, 2013·10 cites·14 claims
- 0485US7943635B2Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 17, 2011·7 cites·9 claims
- 0584US7834016B2Inhibitors of the interaction between MDM2 and p53JANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 16, 2010·8 cites·36 claims
- 0681US7241777B2Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 10, 2007·14 cites·8 claims
- 0775US8778966B2Quinolinone derivatives as PARP and tank inhibitorsVIALARD JORGE EDUARDO·Filed 2012·Granted Jul 15, 2014·3 cites·6 claims
- 0875US8404683B2Inhibitors of the interaction between MDM2 and P53LACRAMPE JEAN FERAND ARMAND·Filed 2010·Granted Mar 26, 2013·6 cites·2 claims
- 0974US8168644B2Quinazolinone derivatives as tubulin polymerization inhibitorsFREYNE EDDY JEAN EDGARD·Filed 2009·Granted May 1, 2012·2 cites·7 claims
- 1073US8377961B2Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53JANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 19, 2013·2 cites·2 claims
- 1173US8232298B2Inhibitors of the interaction between MDM2 and P53LACRAMPE JEAN FERNAND ARMAND·Filed 2007·Granted Jul 31, 2012·3 cites·17 claims
- 1272US9150540B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 6, 2015·1 cites·8 claims
- 1372US7449463B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Nov 11, 2008·6 cites·36 claims
- 1471US8088795B2Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53LACRAMPE JEAN FERNAND ARMAND·Filed 2007·Granted Jan 3, 2012·1 cites·6 claims
- 1567US8889866B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitorsAngibaud Patrick René·Filed 2009·Granted Nov 18, 2014·1 cites·8 claims
- 1666US11267804B2(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activityJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 8, 2022·0 cites·4 claims
- 1755US2024101554A1Cyclin-dependent kinase 7 (cdk7) non-covalent inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1854US8278455B25- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Oct 2, 2012·0 cites·12 claims
- 1954US2018327401A1Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 2053US8883837B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Nov 11, 2014·0 cites·28 claims
- 2149US2007093502A15- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2004·Application pending·0 cites
- 2248US9598396B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 21, 2017·0 cites·2 claims
- 2347US10980725B2Cosmetic compositions and method of treating the skinJOHNSON & JOHNSON CONSUMER INC·Filed 2018·Granted Apr 20, 2021·0 cites·10 claims
- 2444US10526316B2Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 7, 2020·0 cites·12 claims
- 2543US8044073B2Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Oct 25, 2011·0 cites·29 claims
- 2639US11130751B2Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Sep 28, 2021·0 cites·10 claims
- 2739US2019263804A1Azabenzimidazole derivatives as pi3k beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2838US10894793B2Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 19, 2021·0 cites·5 claims
- 2935US10202387B2Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 12, 2019·0 cites·14 claims
- 3035US10087187B2Imidazopyridazine derivatives as PI3KB inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 2, 2018·0 cites·14 claims
- 3129US9527798B2Cyclopropylboronic compounds, preparation process thereof and use thereofDIVERCHIM·Filed 2013·Granted Dec 27, 2016·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Christophe Meyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →